Teva Pharmaceuticals USA (North Wales, Pa) recently announced the introduction and availability of Ofloxacin Tablets. This product is AB-rated and is bioequivalent to Ortho-McNeil?s Floxin tablets. The product is prescribed to patients to reduce the development of drug-resistant bacteria and to maintain the effectiveness of this and other antibacterial drugs. Ofloxacin Tablets are indicated for the treatment of adults with mild-to-moderate infections (unless otherwise indicated) caused by susceptible strains of designated microorganisms. These infections include chronic bronchitis, community-acquired pneumonia, and acute pelvic inflammatory disease, among others. Ofloxacin Tablets 200, 300, and 400 mg are available in bottle sizes of 100. For more information, visit www.tevapharmusa.com.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs